International Clinical Trial: Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467759) titled 'Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy' on March 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).

Primary Sponsor: Tishreen University

Condition: Radiation-induced Oral Mucositis

Intervention: Drug: benzydamine hydrochloride

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 20, 2025

Target Sample Size: 35

Countries of Recruitment: Syria

To know more, visit https://clinicaltrials.gov/study/NCT0746...